Galera Therapeutics, Inc.

GRTXOTCHealthcare● Active

$0.09

$-0.00(-4.09%)

Market Cap$6678571

P/E Ratio—

52W High$0.15

52W Low$0.015

Avg Volume298K

Open$0.09

Beta2.59

Overview

Galera Therapeutics, Inc. (GRTX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

GRTX · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$6.4M▼ -23.1% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$6.4M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-23.1%

vs prior fiscal year

Latest Quarter

$5.5M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$6.4MCash on Hand

Total Debt$0Total Debt

Net Cash / Net Debt+$6.4MNet Cash Position

Cash vs Debt Ratio

Cash 100%Galera Therapeutics, Inc. cash as % of market cap: 95.45%% · MCap $0BDebt 0%

Galera Therapeutics, Inc. has a net cash position of $6.4M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$6.4M − $0 = +$6.4M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

GRTX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

GRTX cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$6.4M-23.1%

Dec 31, 2024FY$8.3M-54.6%

Dec 31, 2023FY$18.3M-42.2%

Dec 31, 2022FY$31.6M-55.6%

Dec 31, 2021FY$71.2M-2.1%

GRTX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

GRTX vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Galera Therapeutics, Inc.YOU

GRTX

$6.4M$7M95.5%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Galera Therapeutics, Inc. (GRTX) cash on hand as of December 31, 2025 is $6.4M, comprising $6.4M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Galera Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Galera Therapeutics, Inc. cash reserves or cash position.

Galera Therapeutics, Inc. annual cash on hand history shows decreased -23.1% in 2025: decreased -23.1% in 2025. Galera Therapeutics, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Galera Therapeutics, Inc. carries total debt of $0 against cash of $6.4M, resulting in a net cash position of +$6.4M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

GRTX cash on hand · 5 questions

As of December 31, 2025, Galera Therapeutics, Inc. (GRTX) has $6,375,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $6,375,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $5,500,000. Data sourced from the annual 10-K filing via FMP.

GRTX cash on handGRTX cash reservesGRTX cash 2025how much cash does GRTX have

▸ Source: FMP /balance-sheet-statement · US GAAP · Galera Therapeutics, Inc. · Galera Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025